The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry

被引:15
|
作者
Lee, Kyung-Jong [1 ]
Shang, Zeng-Fu [1 ,2 ]
Lin, Yu-Fen [1 ]
Sun, Jingxin [1 ]
Morotomi-Yano, Keiko [1 ]
Saha, Debabrata [1 ]
Chen, Benjamin P. C. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA
[2] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Sch Radiol & Interdisciplinary Sci,Dept Radiobiol, Suzhou, Jiangsu, Peoples R China
来源
NEOPLASIA | 2015年 / 17卷 / 04期
基金
美国国家卫生研究院;
关键词
DOUBLE-STRAND BREAK; HUMAN SOMATIC-CELLS; CYCLIN B1; MICROTUBULE NUCLEATION; CHROMOSOMAL STABILITY; CANCER-THERAPY; M-PHASE; PHOSPHORYLATION; PLK1; MITOSIS;
D O I
10.1016/j.neo.2015.02.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the key regulator of the non-homologous end joining pathway of DNA double-strand break repair. We have previously reported that DNA-PKcs is required for maintaining chromosomal stability and mitosis progression. Our further investigations reveal that deficiency in DNA-PKcs activity caused a delay in mitotic entry due to dysregulation of cyclin-dependent kinase 1 (Cdk1), the key driving force for cell cycle progression through G2/M transition. Timely activation of Cdk1 requires polo-like kinase 1 (Plk1), which affects modulators of Cdk1. We found that DNA-PKcs physically interacts with Plk1 and could facilitate Plk1 activation both in vitro and in vivo. Further, DNA-PKcs-deficient cells are highly sensitive to Plk1 inhibitor BI2536, suggesting that the coordination between DNA-PKcs and Plk1 is not only crucial to ensure normal cell cycle progression through G2/M phases but also required for cellular resistance to mitotic stress. On the basis of the current study, it is predictable that combined inhibition of DNA-PKcs and Plk1 can be employed in cancer therapy strategy for synthetic lethality.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 50 条
  • [41] Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase
    Douglas, P
    Sapkota, GP
    Morrice, N
    Yu, YP
    Goodarzi, AA
    Merkle, D
    Meek, K
    Alessi, DR
    Lees-Miller, SP
    BIOCHEMICAL JOURNAL, 2002, 368 (01) : 243 - 251
  • [42] Proteolytic cleavage of the catalytic subunit of DNA-dependent protein kinase during poliovirus infection
    Graham, KL
    Gustin, KE
    Rivera, C
    Kuyumcu-Martinez, NM
    Choe, SS
    Lloyd, RE
    Sarnow, P
    Utz, PJ
    JOURNAL OF VIROLOGY, 2004, 78 (12) : 6313 - 6321
  • [43] Human DNA-dependent protein kinase catalytic subunit deficiency: A comprehensive review and update
    Adelon, Jihane
    Abolhassani, Hassan
    Esenboga, Saliha
    Fouyssac, Fanny
    Cagdas, Deniz
    Tezcan, Ilhan
    Kuskonmaz, Baris
    Cetinkaya, Duygu
    Suarez, Felipe
    Mahdaviani, Seyed Alireza
    Plassart, Samira
    Mathieu, Anne-Laure
    Fabien, Nicole
    Malcus, Christophe
    Morfin-Sherpa, Florence
    Billaud, Genevieve
    Tusseau, Maud
    Benezech, Sarah
    Walzer, Thierry
    De Villartay, Jean-Pierre
    Bertrand, Yves
    Belot, Alexandre
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (05)
  • [44] Regulating a key mitotic regulator, polo-like kinase 1 (PLK1)
    Colicino, Erica G.
    Hehnly, Heidi
    CYTOSKELETON, 2018, 75 (11) : 481 - 494
  • [45] Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit
    Jin, SF
    Kharbanda, S
    Mayer, B
    Kufe, D
    Weaver, DT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) : 24763 - 24766
  • [46] Polo-like kinase 3 is required for entry into S phase
    Zimmerman, Wendy C.
    Erikson, Raymond L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (06) : 1847 - 1852
  • [47] The balance of Polo-like kinase 1 in tumorigenesis
    Lin-Yu Lu
    Xiaochun Yu
    Cell Division, 4
  • [48] The CINs of Polo-Like Kinase 1 in Cancer
    Cunningham, Chelsea E.
    MacAuley, Mackenzie J.
    Vizeacoumar, Frederick S.
    Abuhussein, Omar
    Freywald, Andrew
    Vizeacoumar, Franco J.
    CANCERS, 2020, 12 (10) : 1 - 26
  • [49] The balance of Polo-like kinase 1 in tumorigenesis
    Lu, Lin-Yu
    Yu, Xiaochun
    CELL DIVISION, 2009, 4
  • [50] Developing polo-like kinase 1 inhibitors
    Huang, Xufeng
    Xie, Zhouling
    Liao, Chenzhong
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (10) : 869 - 871